Reduction of interstitial fluid pressure after TNF-oa treatment of three human melanoma xenografts
1996

Reducing Fluid Pressure in Melanoma Tumors with TNF-alpha

Sample size: 121 publication Evidence: moderate

Author Information

Author(s): CA Kristensen, M Nozue, Y Boucher, RK Jain

Primary Institution: Harvard Medical School, Massachusetts General Hospital

Hypothesis

Can TNF-alpha reduce interstitial fluid pressure in human melanoma xenografts?

Conclusion

TNF-alpha significantly reduced interstitial fluid pressure in melanoma tumors after treatment.

Supporting Evidence

  • TNF-alpha reduced interstitial fluid pressure to 54-64% of control values after 5 hours.
  • Mean arterial blood pressure decreased to 70% of control values after TNF-alpha treatment.
  • No significant difference in tumor size was found between treated and untreated groups.

Takeaway

This study found that a treatment called TNF-alpha can help lower the pressure inside melanoma tumors, which might help deliver medicine better.

Methodology

Three human melanoma cell lines were injected into nude mice, and the effects of TNF-alpha on interstitial fluid pressure and mean arterial blood pressure were measured.

Limitations

The pressure-lowering effect of TNF-alpha was not sustained beyond 24 hours.

Participant Demographics

Male nude mice were used for the experiments.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication